Historical record - last NADAC publication: 12/21/2016

Product Information

MORPHINE SULFATE ER 120 MG CAP is a generic product labeled by Actavis Pharma, Inc., priced at $15.6837 per EA under NDC 00228309311. Its NADAC has been published 182 times since Jul 23, 2014.

The High Outlier badge above means this manufacturer's average price in the Morphine sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

MORPHINE SULFATE ER 120 MG CAP

Morphine sulfate
$15.6837per EA
High Outlier
DEA Schedule CII

Strength

120 mg/1

NDC

00228309311

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

12/21/2016

Active Ingredients

MORPHINE SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA079040

On Market Since

2/4/2014

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for MORPHINE SULFATE ER 120 MG CAP has been published 182 times since Jul 23, 2014, and over the history we have for it it has risen 4.5%. The table below summarizes its recorded NADAC range and movement.

Current price$15.6837 per EA
All-time high$17.2355 (Oct 15, 2014)
All-time low$15.0059 (Jul 23, 2014)
Median price$15.6837
Average price$15.8073
Largest weekly change-10.5% (Jun 22, 2016)
Weeks tracked182
Tracking sinceJul 23, 2014

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+4.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Morphine sulfate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of MORPHINE SULFATE ER 120 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULFATE ER 120 MG CAP, manufactured by Actavis Pharma, Inc., is $15.6837 per EA (NDC 00228309311), effective Jan 10, 2018.

How has the price of MORPHINE SULFATE ER 120 MG CAP changed over time?

Over the history we have for it, the NADAC for MORPHINE SULFATE ER 120 MG CAP has risen 4.5%. It has been tracked across 182 weekly CMS publications since Jul 23, 2014.

What are the highest and lowest recorded NADAC prices for MORPHINE SULFATE ER 120 MG CAP?

Since Jul 23, 2014, the NADAC for MORPHINE SULFATE ER 120 MG CAP has ranged from a low of $15.0059 (Jul 23, 2014) to a high of $17.2355 (Oct 15, 2014), with a median of $15.6837 per EA.

Are there cheaper alternatives to MORPHINE SULFATE ER 120 MG CAP?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MORPHINE SULFATE ER 120 MG CAP, so no direct lower-cost alternative is listed.

Who manufactures MORPHINE SULFATE ER 120 MG CAP?

MORPHINE SULFATE ER 120 MG CAP (NDC 00228309311) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.